<p>Neutralizing antibodies specific of AHSV-4 or AHSV-9 were analyzed in sera of immunized mice by VNT. Neutralization titers at day 15 post-booster treatment in sera of animals immunized with DNA/rMVA (A) or rMVA/rMVA (B) expressing VP2, NS1, or VP2/NS1 are shown. (▴) Non-Immunized, (♦) VP2 immunized, (▪) NS1 immunized, and (•) VP2/NS1 immunized. Means are presented as bars (⁃). Asterisks (*) indicate statistically significant differences (<i>P</i><0.05) between immunized and non-immunized mice, calculated by signed rank test.</p
<p>Mice were immunized i.n. with 1×10<sup>9</sup> vp of Ad4wt virus per mouse to establish pre-exist...
<p><b>(A)</b> Mean ± sem neutralizing antibody titer in pre-challenge (Day 60) serum collected from ...
<p>Mouse groups were immunized with H1HA, H5b+H7H9b+H1HA, or ΔE1E3 twice at four week intervals. Fou...
<p>The presence of antibodies specific of VP2, VP7, and NS1 in serum of immunized (A) and non-immuni...
<p>Mice (8 weeks old, 6 per group) were immunized twice by heterologous prime-boost vaccination with...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Serum samples collected from the mice at days 0 (first vaccination), 21(second vaccination), 35(c...
<p>(A) Mice were immunized three times with DNA encoding different MPER display mutants and boosted ...
<p>Mice (8 weeks old, 6 per group) were immunized twice by heterologous prime boost vaccination with...
<p>(A) Mice (n = 5–6/group) were immunized with VLPs containing different MPER display mutant either...
<p>Sera from groups of mice immunized intramuscularly with DNA vaccines with and without the CpG ODN...
<p>Non-vaccinated control and MVA-VP2 vaccinated mice were challenged with AHSV-4. Survival rates (d...
<p><b>A</b>. Three groups of 16 BALB/c mice were immunized twice intraperitonealy with 10 µg of VLP-...
<p><b>A</b> & <b>B</b>) Balb/c mice were immunized i.m. at weeks 0 and 2 with 50 µg of pSG2-Ag85A or...
<p>Sera from mice injected intramuscularly with PBS, AcHERV-GmCSF, killed vaccine alone, or killed v...
<p>Mice were immunized i.n. with 1×10<sup>9</sup> vp of Ad4wt virus per mouse to establish pre-exist...
<p><b>(A)</b> Mean ± sem neutralizing antibody titer in pre-challenge (Day 60) serum collected from ...
<p>Mouse groups were immunized with H1HA, H5b+H7H9b+H1HA, or ΔE1E3 twice at four week intervals. Fou...
<p>The presence of antibodies specific of VP2, VP7, and NS1 in serum of immunized (A) and non-immuni...
<p>Mice (8 weeks old, 6 per group) were immunized twice by heterologous prime-boost vaccination with...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Serum samples collected from the mice at days 0 (first vaccination), 21(second vaccination), 35(c...
<p>(A) Mice were immunized three times with DNA encoding different MPER display mutants and boosted ...
<p>Mice (8 weeks old, 6 per group) were immunized twice by heterologous prime boost vaccination with...
<p>(A) Mice (n = 5–6/group) were immunized with VLPs containing different MPER display mutant either...
<p>Sera from groups of mice immunized intramuscularly with DNA vaccines with and without the CpG ODN...
<p>Non-vaccinated control and MVA-VP2 vaccinated mice were challenged with AHSV-4. Survival rates (d...
<p><b>A</b>. Three groups of 16 BALB/c mice were immunized twice intraperitonealy with 10 µg of VLP-...
<p><b>A</b> & <b>B</b>) Balb/c mice were immunized i.m. at weeks 0 and 2 with 50 µg of pSG2-Ag85A or...
<p>Sera from mice injected intramuscularly with PBS, AcHERV-GmCSF, killed vaccine alone, or killed v...
<p>Mice were immunized i.n. with 1×10<sup>9</sup> vp of Ad4wt virus per mouse to establish pre-exist...
<p><b>(A)</b> Mean ± sem neutralizing antibody titer in pre-challenge (Day 60) serum collected from ...
<p>Mouse groups were immunized with H1HA, H5b+H7H9b+H1HA, or ΔE1E3 twice at four week intervals. Fou...